CARDIOL THERAPEUTICS INC. (CRDL)
Clinical trial NCT04695106 updates: 1. status: UNKNOWN → RECRUITING 2. completion date: 2026-03-31 → 2026-08-31 3. primary completion date: 2024-03-01 → 2026-07-11 4. enrollment: 2230 → 1194 participants 5. masking: TRIPLE → NONE 6. collaborators added: University of Warmia and Mazury in Olsztyn, American Heart of Poland
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical